 |
|
Prostate Cancer Screening (PDQ®)
[ patient ] [ health professional ]
Expert-reviewed information summary about tests used to detect or screen for prostate cancer.
Clinical Trials to Screen for Prostate Cancer
Check for prostate cancer screening trials from NCI's PDQ® Cancer Clinical Trials Registry now accepting patients. The list of clinical trials can be refined by location, stage of disease, drug, and other features.
Early Prostate Cancer
A fact sheet that describes risk factors for prostate cancer, and symptoms and treatment options for localized disease. Discusses available screening tests. National Cancer Institute Fact Sheet 5.23
Understanding Prostate Changes: A Health Guide for Men
This booklet for men describes changes that may occur in the prostate over time.
U.S. Cancer Screening Trial Shows No Early Mortality Benefit from Annual Prostate Cancer Screening
Six annual screenings for prostate cancer led to more diagnoses of the disease, but no fewer prostate cancer deaths, according to a major new report from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, a 17-year project of the NCI. The PLCO was designed to provide answers about the effectiveness of prostate cancer screening.
Panel Recommends Against PSA Testing in Men 75 or Older
The U.S. Preventive Services Task Force is advising against the routine use of prostate-specific antigen (PSA) testing to screen for prostate cancer in men age 75 and older, according to guidelines published in the August 5, 2008, Annals of Internal Medicine.
Prostate-Specific Antigen (PSA) Test
A fact sheet that describes the PSA screening test for prostate cancer and explains the benefits and limitations of the test. National Cancer Institute Fact Sheet 5.29
Prostate Cancer Research Results From the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, or PLCO, is a large-scale clinical trial to determine whether certain cancer screening tests reduce deaths from these cancers. This fact sheet describes the initial results about prostate cancer screening from the PLCO. National Cancer Institute Fact Sheet 5.36
Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
A large-scale clinical trial to determine whether certain cancer screening tests reduce deaths from prostate, lung, colorectal, and ovarian cancer. In addition, there are numerous epidemiologic and ancillary studies going on that will answer other crucial questions about these cancers and these screening tests.
Protein Patterns in Blood May Predict Prostate Cancer Diagnosis
Patterns of proteins found in patients' blood serum may help distinguish between prostate cancer and benign conditions, scientists from the NCI and FDA report today in the Journal of the National Cancer Institute.
Interpreting Laboratory Test Results
A fact sheet that describes the role of screening and diagnostic laboratory tests. Includes a brief discussion of factors affecting the results. National Cancer Institute Fact Sheet 5.27
Tumor Markers: Questions and Answers
A fact sheet that defines tumor markers and describes how they can be used to aid diagnosis and treatment. National Cancer Institute Fact Sheet 5.18
|
|
|
